$4.1M
sold in all offerings
Unravel Biosciences, Inc. is a corporation based in Medford, MA in the Biotechnology industry group. From August 24, 2026 to August 24, 2026 it filed 1 private fundraising filing for 1 offering and reported $4.1 million sold in all.
Updated October 10, 2026 · newest filing Aug 24, 2026
Amount sold
$4.1M
All offerings, newest filing of each
Offered
$4.5M
Total amount sought
Offerings
1
1 filing with amendments
Newest offering
$4.1M
Sold, first filed Aug 24, 2026
Investors
2
In the newest offering
Min. investment
-
In the newest offering
Facts
- Type
- Corporation
- Place
- Medford, MA
- Industry group
- Biotechnology
- Listed
- No
- First filing
- August 24, 2026
- Newest filing
- August 24, 2026
- Exemptions
- 506(b)
Offerings
1 offering, newest first, each at its newest filing
| First filed | Amount sold | Offered | Investors | Min. investment | Exemptions | Securities |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | $4.1M | $4.5M | 2 | - | 506(b) | Debt, Options or warrants |
Filing history
1 filing, newest first. An amendment updates an earlier offering.
| Filed | Kind | Amount sold | Offered | Investors |
|---|---|---|---|---|
| Aug 24, 2026 | New offering | $4.1M | $4.5M | 2 |
Related pages
Questions and answers
How much has Unravel Biosciences, Inc. raised in private offerings?
$4.1 million sold in 1 private offering reported from Aug 24, 2026 to Aug 24, 2026, counting each offering once at its newest filing.
When did Unravel Biosciences, Inc. last file about a private offering?
August 24, 2026. Its newest offering reported $4.1 million sold of $4.5 million offered to 2 investors.
Which exemption does Unravel Biosciences, Inc. use?
506(b). Rule 506(b) does not allow public advertising.
Is Unravel Biosciences, Inc. a listed company?
No ticker is linked to this issuer, so it is private or no longer listed.
These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.